Analysts have clear opinions on AMPH.

Amphastar Pharmaceuticals, Inc. (AMPH) is followed by analysts on the street.

null from rates it a .

Similarly, null of a with a target of .

The consensus on the street is null.

What does Amphastar Pharmaceuticals, Inc.(AMPH) do ?
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Amphastar Pharmaceuticals, Inc. (AMPH) Insider Trades

Multiple company employees have indulged in significant insider trading. Amphastar Pharmaceuticals, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

CFO, SVP, Treasurer, Peters William J : S – Sale(-$65,539) of AMPH in the trading session of 2020-03-13.

Dir Petersen Floyd F. : S – Sale(-$7,782) of AMPH in the trading session of 2020-03-02.

Pres, GC Shandell Jason B. : S – Sale+OE(-$876,765) of Amphastar Pharmaceuticals, Inc. in the trading session of 2020-02-05.

Looking for stocks just like AMPH?

Based on Wall Street analyst research, several stocks are similar to AMPH
They are:
– PFE [Info can be found here: ]
– AKRX [Info can be found here: ]
– TEVA [Info can be found here: ]